EV/EBITDA
-0.75
+0.04+5.06%
50 min ago
Summary
- As of February 8, 2025, ALGS EV/EBITDA is -0.75, with a rise of +0.04 (+5.06%) during the most recent trading day.
- Over the past year, ALGS EV/EBITDA has dropped by -1.61 (-187.21%).
- ALGS EV/EBITDA is now -183.33% below its all-time high of 0.90.
Performance
ALGS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALGS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.1% | -5.1% | -3.7% |
| 1 m1 month | +44.4% | -44.2% | -36.5% |
| 3 m3 months | -733.3% | +748.0% | +177.9% |
| 6 m6 months | -733.3% | +734.5% | +95.4% |
| ytdytd | +37.5% | -37.3% | -30.2% |
| 1 y1 year | -187.2% | +195.3% | +54.3% |
| 5 y5 years | - | - | - |
ALGS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -17.2% | -1.35 | +44.4% | |
| 3 m | 3-month | -0.09 | -733.3% | -1.53 | +51.0% |
| 6 m | 6-month | 0.11 | -781.8% | -1.53 | +51.0% |
| 1 y | 1-year | 0.90 | -183.3% | -1.53 | +51.0% |
| 3 y | 3-year | 0.90 | -183.3% | -1.53 | +51.0% |
| 5 y | 5-year | 0.90 | -183.3% | -15.58 | +95.2% |
| alltime | all time | 0.90 | -183.3% | -15.58 | +95.2% |
Aligos Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.75(-37.5%) |
| 2024 | -1.20(-236.4%) |
| 2023 | 0.88(+193.3%) |
| Date | Value |
|---|---|
| 2022 | 0.30(-111.2%) |
| 2021 | -2.68(-68.5%) |
| 2020 | -8.51 |
FAQ
- What is Aligos Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aligos Therapeutics?
- What is ALGS EV/EBITDA year-to-date change?
- What is Aligos Therapeutics EV/EBITDA year-on-year change?
What is Aligos Therapeutics EV/EBITDA?
The current EV/EBITDA of ALGS is -0.75
What is the all time high EV/EBITDA for Aligos Therapeutics?
Aligos Therapeutics all-time high EV/EBITDA is 0.90
What is ALGS EV/EBITDA year-to-date change?
Aligos Therapeutics EV/EBITDA has changed by +0.45 (+37.50%) since the beginning of the year
What is Aligos Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALGS EV/EBITDA has changed by -1.61 (-187.21%)